Fuse Medical, Inc. (FZMD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1565 NORTH CENTRAL EXPRESSWAY RICHARDSON, TX 75080 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 148 | 553 | 1,187 | 1,099 | 844 | 805 | |||
| Cash and cash equivalent | 148 | 553 | 1,187 | 1,099 | 844 | 805 | |||
| Receivables | 3,997 | 3,529 | 4,428 | 6,174 | 5,226 | 6,570 | |||
| Inventory, net of allowances, customer advances and progress billings | 9,495 | 8,736 | 6,981 | 7,856 | 11,076 | 10,627 | |||
| Inventory | 9,495 | 8,736 | 6,981 | 7,856 | 11,076 | 10,627 | |||
| Other undisclosed current assets | 126 | 6 | 24 | 40 | 30 | 32 | |||
| Total current assets: | 13,765 | 12,825 | 12,621 | 15,169 | 17,176 | 18,034 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1 | 7 | 18 | 33 | 43 | 17 | |||
| Long-term investments and receivables, including: | 2,833 | 2,182 | 1,670 | ||||||
| Accounts and financing receivable, after allowance for credit loss | |||||||||
| Other undisclosed long-term investments and receivables | 2,833 | 2,182 | 1,670 | ||||||
| Intangible assets, net (including goodwill) | 3,164 | 3,290 | 3,111 | 3,180 | 4,193 | 821 | |||
| Goodwill | 1,973 | 1,973 | 1,973 | 1,973 | 2,905 | 821 | |||
| Intangible assets, net (excluding goodwill) | 1,191 | 1,317 | 1,138 | 1,207 | 1,288 | ||||
| Other undisclosed noncurrent assets | 761 | 375 | |||||||
| Total noncurrent assets: | 5,997 | 5,480 | 4,798 | 3,212 | 4,997 | 1,213 | |||
| TOTAL ASSETS: | 19,763 | 18,304 | 17,419 | 18,381 | 22,173 | 19,247 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,241 | 7,360 | 5,821 | 6,056 | 5,497 | 4,419 | |||
| Accounts payable | 5,700 | 4,462 | 3,237 | 2,753 | 2,713 | 2,588 | |||
| Accrued liabilities | 4,540 | 2,898 | 2,585 | 3,303 | 2,784 | 1,831 | |||
| Debt | 1,997 | 2,433 | 913 | 1,753 | 1,477 | 3,415 | |||
| Due to related parties | 150 | 150 | 150 | 150 | 150 | ||||
| Other undisclosed current liabilities | 150 | 364 | |||||||
| Total current liabilities: | 12,388 | 9,942 | 7,248 | 7,958 | 7,125 | 7,984 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 7,686 | 11,794 | 12,136 | 11,645 | 13,582 | 19,245 | |||
| Due to related parties | 200 | 200 | 200 | ||||||
| Business combination, contingent consideration, liability | 7,486 | 11,594 | 11,936 | 11,645 | 13,582 | 19,245 | |||
| Other undisclosed noncurrent liabilities | 148 | ||||||||
| Total noncurrent liabilities: | 7,686 | 11,794 | 12,284 | 11,645 | 13,582 | 19,245 | |||
| Total liabilities: | 20,073 | 21,736 | 19,532 | 19,604 | 20,706 | 27,229 | |||
| Equity | |||||||||
| Equity, attributable to parent | (311) | (3,432) | (2,113) | (1,222) | 1,467 | (7,982) | |||
| Common stock | 739 | 729 | 731 | 731 | 715 | 672 | |||
| Additional paid in capital | 1,468 | 1,455 | 1,184 | 642 | (8,653) | ||||
| Retained earnings (accumulated deficit) | (2,518) | (5,616) | (4,028) | (2,596) | 752 | ||||
| Total equity: | (311) | (3,432) | (2,113) | (1,222) | 1,467 | (7,982) | |||
| TOTAL LIABILITIES AND EQUITY: | 19,763 | 18,304 | 17,419 | 18,381 | 22,173 | 19,247 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 18,645 | 20,414 | 21,399 | 22,900 | 26,342 | 26,407 | ||
| Cost of revenue | (7,103) | (8,479) | (8,695) | (11,763) | (13,353) | (14,582) | ||
| Gross profit: | 11,542 | 11,936 | 12,704 | 11,137 | 12,989 | 11,825 | ||
| Operating expenses | (12,357) | (14,131) | (13,732) | (15,487) | (14,948) | (11,007) | ||
| Operating income (loss): | (815) | (2,196) | (1,028) | (4,350) | (1,958) | 818 | ||
| Nonoperating income (expense) | 3,937 | 625 | (386) | 1,815 | (134) | (118) | ||
| Interest and debt expense | (171) | (78) | (95) | (122) | (134) | 43 | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 95 | 122 | 5,797 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 2,950 | (1,648) | (1,414) | (2,535) | 3,571 | 743 | ||
| Other undisclosed income from continuing operations before income taxes | 171 | 78 | ||||||
| Income (loss) from continuing operations before income taxes: | 3,122 | (1,570) | (1,414) | (2,535) | 3,571 | 743 | ||
| Income tax expense (benefit) | (24) | (18) | (19) | (781) | 387 | |||
| Income (loss) from continuing operations: | 3,098 | (1,588) | (1,432) | (3,316) | 3,958 | 743 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (1,588) | (1,432) | (3,316) | 3,958 | 743 | ||
| Other undisclosed net income | ||||||||
| Net income (loss): | 3,098 | (1,588) | (1,432) | (3,316) | 3,958 | 743 | ||
| Other undisclosed net loss attributable to parent | (43) | |||||||
| Net income (loss) available to common stockholders, diluted: | 3,098 | (1,588) | (1,432) | (3,316) | 3,958 | 700 | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 3,098 | (1,588) | (1,432) | (3,316) | 3,958 | 743 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 3,098 | (1,588) | (1,432) | (3,316) | 3,958 | 743 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.